InvestorsHub Logo
icon url

hope4patients

02/24/23 2:11 PM

#570797 RE: meirluc #570795

I believe a significant number of patients that were “excluded” due to progression during that time were placed in an “information arm” of the trial, given DCVAX-L, and followed.
icon url

newman2021

02/24/23 2:47 PM

#570813 RE: meirluc #570795

Wow it is a good paper overall that is 100% devoted to critically evaluating our DcVaxL phase 3 trial. Thanks for the German endorsement!!!!!!!!!!!!!!!
icon url

sentiment_stocks

02/24/23 3:12 PM

#570826 RE: meirluc #570795

Great points, meirluc. :)
icon url

Mionaer1

02/25/23 8:59 AM

#571010 RE: meirluc #570795

Thanks Meirluc for clarification.